Critical Therapeutics, Inc. 2005 Company Goals Statement

Contract Categories: Human Resources › Bonus & Incentive Agreements
Summary

This document outlines the 2005 company goals for Critical Therapeutics, Inc. The goals include enhancing the commercial value of the drug Zileuton through regulatory filings and product launch, advancing research and development for other products, maintaining the company's financial position by managing cash, and building an effective organization by recruiting and retaining employees. The document sets out the company's key objectives for the year but does not impose specific legal obligations or timeframes.

Read More Arrow
EX-10.42 8 b53319ctexv10w42.txt EX-10.42 2005 COMPANY GOALS Exhibit 10.42 CRITICAL THERAPEUTICS, INC. 2005 COMPANY GOALS GOAL ONE: TO ENHANCE THE COMMERCIAL VALUE OF ZILEUTON - Make regulatory filings - Launch Zyflo(R) - Achieve business development goals GOAL TWO: TO PROGRESS THE COMPANY RESEARCH AND DEVELOPMENT PIPELINE - Achieve pre-clinical and clinical development milestones and business development goals for other product candidates GOAL THREE: MAINTAIN THE COMPANY'S FINANCIAL POSITION - Manage cash balance GOAL FOUR: CREATE AN EFFECTIVE ORGANIZATION - Recruit and retain employees - Make important key appointments